Literature DB >> 3800908

A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.

E M Prence, K O Garrett, R H Glew.   

Abstract

Extraction of control human spleen glucocerebrosidase with sodium cholate and butan-l-ol reversibly inactivates the enzyme in terms of its ability to hydrolyse the water-soluble substrate 4-methylumbelliferyl beta-D-glucopyranoside (MUGlc). The acidic brain lipid galactocerebroside 3-sulphate (sulphatide) reconstitutes beta-glucosidase activity in a strongly concentration-dependent manner. In this study we show that sulphatide exhibits three critical micellar concentrations (CMCs): CMC1, 3.72 microM; CMC2, 22.6 microM; CMC3, 60.7 microM. We designate the aggregates formed at these CMCs as primary, secondary and tertiary micelles respectively. From the results of kinetic studies performed at various sulphatide concentrations (0.012-248 microM), we found that sulphatide monomers (less than 3 microM) decreased the Km (for MUGlc) of control glucocerebrosidase from 11 to 4.6 mM, and lowered the Vmax. 2-fold. However, secondary and tertiary micelles were required for expression of high control glucocerebrosidase activities. Glucocerebrosidase prepared from the spleen of a patient with non-neuronopathic type 1 Gaucher's disease exhibited a very low Km (2.8 mM) even in the absence of exogenous lipid, and sulphatide monomers had no effect on the mutant enzyme's Km or Vmax. However, secondary or tertiary micelles markedly increased the Vmax. of the type 1 glucocerebrosidase to 60% of the corresponding control enzyme value. In contrast, for the glucocerebrosidase of the neuronopathic type 2 case, although sulphatide decreased the Km from 9.2 to 1.7 mM, the Vmax. never reached more than 5% that of the control enzyme, even at high concentrations of sulphatide. In addition, we found that secondary and tertiary sulphatide micelles enhanced the rate of inactivation of all three glucocerebrosidase preparations by chymotrypsin. Collectively, these results indicate the presence of two sulphatide-binding sites on glucocerebrosidase: one that enhances substrate binding, and another that enhances catalysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800908      PMCID: PMC1147041          DOI: 10.1042/bj2370655

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  Glucocerebrosidase: reconstitution from macromolecular components depends on acidic phospholipids.

Authors:  M W Ho; N D Light
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

3.  Microheterogeneity of the carbohydrate group of aspergillus oryzae alpha-amylase.

Authors:  J F McKelvy; Y C Lee
Journal:  Arch Biochem Biophys       Date:  1969-06       Impact factor: 4.013

4.  Micelles of cerebroside sulphate.

Authors:  H J Jeffrey; A B Roy
Journal:  Aust J Exp Biol Med Sci       Date:  1977-06

5.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.

Authors:  G A Grabowski; S Gatt; J Kruse; R J Desnick
Journal:  Arch Biochem Biophys       Date:  1984-05-15       Impact factor: 4.013

7.  Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.

Authors:  R H Glew; L B Daniels; L S Clark; S W Hoyer
Journal:  J Neuropathol Exp Neurol       Date:  1982-11       Impact factor: 3.685

8.  Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.

Authors:  K O Garrett; E M Prence; R H Glew
Journal:  Arch Biochem Biophys       Date:  1985-04       Impact factor: 4.013

9.  Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.

Authors:  A Basu; R H Glew
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

10.  Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.

Authors:  A Basu; E Prence; K Garrett; R H Glew; J S Ellingson
Journal:  Arch Biochem Biophys       Date:  1985-11-15       Impact factor: 4.013

View more
  2 in total

1.  Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.

Authors:  B C Paton; A Poulos
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.

Authors:  E M Prence
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.